Last month, Todd Hagopian named Clovis Oncology as 1 of 3 takeover candidates. Today CLVS is trading around $76, up more than 10% on double its' normal daily volume making it the third largest position in Todd's Biotech fund.
Last month, Todd Hagopian named Clovis Oncology as 1 of 3 takeover candidates. Today CLVS is trading around $76, up more than 10% on double its' normal daily volume making it the third largest position in Todd's Biotech fund.
Share this Article
Recommended